These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23571545)

  • 1. Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
    van Hasselt JG; van Eijkelenburg NK; Huitema AD; Schellens JH; Schouten-van Meeteren AY
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2878-81. PubMed ID: 23571545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe phototoxicity associated with long-term voriconazole treatment.
    Vöhringer S; Schrum J; Ott H; Höger PH
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
    Denning DW; Griffiths CE
    Clin Exp Dermatol; 2001 Nov; 26(8):648-53. PubMed ID: 11722447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Porphyria cutanea tarda revealed by voriconazole].
    Hickman G; Duval A; Picard C; Petit A
    Ann Dermatol Venereol; 2010 Jan; 137(1):36-9. PubMed ID: 20110066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
    Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
    Goyal RK; Gehris RP; Howrie D; Cogley KM; Windreich RM; Venkataramanan R
    Pediatr Blood Cancer; 2014 Jul; 61(7):1325-8. PubMed ID: 24619922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Papy E; Carde A; Ribaud P; Faure P; Touratier S
    Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359
    [No Abstract]   [Full Text] [Related]  

  • 10. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
    Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Sun HL; Zhou X; Shen YF
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole induced bradycardia.
    Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
    Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    Frick MA; Soler-Palacín P; Martín Nalda A; Guarner ME; Nadal CF
    Pediatr Infect Dis J; 2010 May; 29(5):480-1. PubMed ID: 20431387
    [No Abstract]   [Full Text] [Related]  

  • 19. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
    Miller DD; Cowen EW; Nguyen JC; McCalmont TH; Fox LP
    Arch Dermatol; 2010 Mar; 146(3):300-4. PubMed ID: 20083676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.